Opportunity Information: Apply for RFA MD 24 003

This NIH funding opportunity (RFA-MD-24-003) is a discretionary R01 grant that requires a clinical trial and is focused on intervention research for people living with HIV who are also dealing with HIV-associated, non-AIDS comorbidities. The central goal is to improve quality of life and support successful aging across the life course, with a specific emphasis on populations that are highly affected by HIV and experience health disparities, particularly racial and ethnic minority groups and people with lower socioeconomic status. In practice, the announcement is looking for projects that move beyond single-level solutions by developing and testing multilevel, multidisciplinary interventions that can address the real-world mix of medical, behavioral, and social factors that shape comorbidity burden and aging outcomes in people with HIV.

The opportunity is aimed at research that recognizes how non-AIDS comorbidities increasingly drive illness and reduced quality of life among people with HIV, especially as life expectancy has improved. While the notice does not list specific comorbidities in the excerpt provided, the framing clearly points to conditions that commonly cluster with HIV over time and interact with HIV treatment and long-term inflammation, as well as with structural barriers to care. The intent is to support interventions that are relevant across different stages of life (not just older adulthood) and that can measurably improve outcomes connected to well-being and functional health, not merely viral suppression. Because it is “multilevel,” strong applications are typically expected to act at more than one layer at once, for example combining patient-level supports (like symptom management, adherence support, mental health or substance use services) with provider-level changes (like care coordination practices or clinical decision supports) and system or community-level components (like linkage pathways, culturally tailored services, transportation solutions, or partnerships that reduce access barriers).

A major theme is health disparities: the initiative explicitly prioritizes interventions designed for communities that are disproportionately affected and that face inequities tied to race, ethnicity, and socioeconomic position. That means the projects should be designed with equity in mind from the beginning, including culturally responsive approaches, feasible delivery in safety-net settings, and attention to the structural drivers that make comorbidity management harder in the first place. Multidisciplinary work is encouraged, implying teams that can integrate clinical HIV care, chronic disease management, behavioral health, implementation science, community engagement, and social/structural intervention methods, depending on what the intervention targets.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments. The opportunity is also open to nonprofits with and without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations other than small businesses, and small businesses. In addition, the announcement highlights specific categories of eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This wide eligibility list signals NIH’s interest in bringing in community-rooted organizations and minority-serving institutions alongside traditional academic and healthcare research centers, which can be important for designing interventions that are credible, trusted, and sustainable in the communities most affected.

At the same time, there are clear restrictions regarding foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed. In short, the applicant organization must be U.S.-based, and the work cannot include foreign components under NIH’s definition for this funding announcement.

Administratively, the sponsoring agency is the National Institutes of Health (NIH), and the opportunity is categorized under CFDA numbers 93.307 and 93.313. The original closing date listed is 2026-12-11. The excerpt you provided does not specify an award ceiling or the expected number of awards, so applicants would need to review the full announcement for budget and project period expectations, review criteria, and any institute-specific priorities tied to this RFA. Overall, the program is best understood as an NIH push to fund rigorous clinical-trial-based intervention studies that can reduce comorbidity burden and improve day-to-day functioning and long-term aging outcomes for people living with HIV who are most affected by inequities in health and healthcare access.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307, 93.313.
  • This funding opportunity was created on 2023-09-25.
  • Applicants must submit their applications by 2026-12-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MD 24 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)

Previous opportunity: Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MD 24 003

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MD 24 003) also looked into and applied for these:

Funding Opportunity
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 23 301

Funding Number: PAR 23 301
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) Apply for PAR 23 302

Funding Number: PAR 23 302
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 054

Funding Number: RFA AI 23 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 24 006

Funding Number: RFA DE 24 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $650,000
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 23 221

Funding Number: PAR 23 221
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 24 037

Funding Number: PAR 24 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) Apply for PAR 23 228

Funding Number: PAR 23 228
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) Apply for PAR 24 033

Funding Number: PAR 24 033
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 306

Funding Number: PAR 23 306
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) Apply for RFA AI 23 057

Funding Number: RFA AI 23 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA EB 23 006

Funding Number: RFA EB 23 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) Apply for PAR 24 028

Funding Number: PAR 24 028
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) Apply for RFA AA 23 004

Funding Number: RFA AA 23 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,200,000
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) Apply for RFA MD 24 001

Funding Number: RFA MD 24 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,500,000
Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) Apply for RFA AG 24 040

Funding Number: RFA AG 24 040
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required) Apply for RFA NS 24 013

Funding Number: RFA NS 24 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $6,700,000
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) Apply for PAR 24 050

Funding Number: PAR 24 050
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) Apply for PAR 24 051

Funding Number: PAR 24 051
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 059

Funding Number: RFA AI 23 059
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AI 23 060

Funding Number: RFA AI 23 060
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MD 24 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: